[1]
|
World Health Organization (2012) World malaria report 2012. WHO Press, Geneva.
http://www.who.int/malaria/publications/world_malaria_report_2012/wmr2012_factseet.pdf
|
[2]
|
Ridley, R.G. (2002) Medical need, scientific opportunity and the drive for antimalarial drugs. Nature, 415, 686-693.
doi:10.1038/415686a
|
[3]
|
Trager, W. and Jensen, J.B. (1997) Continuous culture of Plasmodium falciparum: Its impact on malaria research. International Journal for Parasitology, 27, 989-1006.
doi:10.1016/S0020-7519(97)00080-5
|
[4]
|
Asahi, H. and Kanazawa, T. (1994) Continuous cultivation of intraerythrocytic Plasmodium falciparum in a serum-free medium with the use of a growth-promoting factor. Parasitology, 109, 397-401.
doi:10.1017/S0031182000080641
|
[5]
|
Cranmer, S.L., Magowan, C., Liang, J., Coppel, R.L. and Cooke, B.M. (1997) An alternative to serum for cultivation of Plasmodium falciparum in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 363-365. doi:10.1016/S0035-9203(97)90110-3
|
[6]
|
Kim, Y.J., et al. (2012) Development of a chemically defined minimal medium for the exponential growth of Leuconostocmesenteroides ATCC8293. Journal of Microbiology and Biotechnology, 22, 1518-1522.
doi:10.4014/jmb.1205.05053
|
[7]
|
Mimura, S., et al. (2011) Growth factor-defined culture medium for human mesenchymal stem cells. International Journal of Developmental Biology, 55, 181-187.
doi:10.1387/ijdb.103232sm
|
[8]
|
Asahi, H. (2009) Plasmodium falciparum: Chemically defined medium for continuous intraerythrocytic growth using lipids and recombinant albumin. Experimental Parasitology, 121, 22-28. doi:10.1016/j.exppara.2008.09.009
|
[9]
|
Makler, M.T. and Hinrichs, D.J. (1993) Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. The American Jornal of Tropical Medicine and Hygiene, 48, 205-210.
|
[10]
|
Druilhe, P., Moreno, A., Blanc, C., Brasseur, P.H. and Jacquier, P. (2001) A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. The American Journal of Tropical Medicine and Hygiene, 64, 233-241.
|
[11]
|
Noedl, H., Wongsrichanalai, C. and Wernsdorfer, W.H. (2003) Malaria drug-sensitivity testing: New assays, new perspectives. Trends in Parasitology, 19, 175-181.
doi:10.1016/S1471-4922(03)00028-X
|
[12]
|
Asahi, H., Kanazawa, T., Hirayama, N. and Kajihara, Y. (2005) Investigating serum factors promoting erythrocytic growth of Plasmodium falciparum. Experimental Parasitology, 109, 7-15.
doi:10.1016/j.exppara.2004.10.002
|
[13]
|
Piper, R.C., Buchanan, I., Choi, Y.H. and Makler, M.T. (2011) Opportunities for improving pLDH-based malaria diagnostic tests. Malaria journal, 10, 213.
doi:10.1186/1475-2875-10-213
|
[14]
|
Izumiyama, S., Omura, M., Takasaki, T., Ohmae, H. and Asahi, H. (2009) Plasmodium falciparum: Development and validation of a measure of intraerythrocytic growth using SYBR Green I in a flow cytometer. Experimental Parasitology, 121, 144-150.
doi:10.1016/j.exppara.2008.10.008
|
[15]
|
Bei, A.K., et al. (2010) A flow cytometry-based assay for measuring invasion of red blood cells by Plasmodium falciparum. American Journal of Hematology, 85, 234-237. doi:10.1002/ajh.21642
|
[16]
|
Somsak, V., Srichairatanakool, S., Yuthavong, Y., Kamchonwongpaisan, S. and Uthaipibull, C. (2012) Flow cytometric enumeration of Plasmodium berghei-infected red blood cells stained with SYBR Green I. Acta tropica, 122, 113-118. doi:10.1016/j.actatropica.2011.12.010
|
[17]
|
Asahi, H., Izumiyama, S., Tolba, M.E. and Kwansa-Bentum, B. (2011) Plasmodium falciparum: Differing effects of non-esterified fatty acids and phospholipids on intraerythrocytic growth in serum-free medium. Experimental Parasitology, 127, 708-713.
doi:10.1016/j.exppara.2010.11.001
|
[18]
|
Asahi, H. (2012) Intraerythrocytic Plasmodium falciparum Growth in Serum-Free Medium with an Emphasis on Growth-Promoting Factors. In: Okwa, O.O., Ed., Malaria Parasites, InTech, Croatia, 73-90. doi:10.5772/33212
|
[19]
|
Asahi, H., Tolba, M.E.M., Tanabe, M. and Ohmae, H. (2013) Molecular factors that are associated with early developmental arrest of intraerythrocytic Plasmodium falciparum. Canadian Journal of Microbiology, 59, 485-493.
doi:10.1139/cjm-2013-0166
|
[20]
|
Grimberg, B.T. (2011) Methodology and application of flow cytometry for investigation of human malaria parasites. Journal of Immunological Methods, 367, 1-16.
doi:10.1016/j.jim.2011.01.015
|
[21]
|
Bouillon, A., Gorgette, O., Mercereau-Puijalon, O. and Barale, J.C. (2013) Screening and evaluation of inhibitors of Plasmodium falciparum merozoite egress and invasion using cytometry. In: Menard, R., Ed., Malaria: Methods and Protocols, Methods in Molecular Biology, Springer Science + Business Media, 523-534.
|
[22]
|
Dondorp, A.M., et al. (2009) Artemisinin resistance in Plasmodium falciparum malaria. The New England Journal of Medicine, 361, 455-467.
doi:10.1056/NEJMoa0808859
|
[23]
|
World Health Organization (2011) Global plan for artemisinin resistance containment. WHO press, Geneva.
|
[24]
|
Kwansa-Bentum, B., et al. (2011) Administrative practices of health professionals and use of artesunate-amodiaquine by community members for treating uncomplicated malaria in southern Ghana: Implications for artemisinin-based combination therapy deployment. Tropical Medicine and International Health, 16, 1215-1224.
doi:10.1111/j.1365-3156.2011.02833.x
|
[25]
|
Kwansa-Bentum, B., et al. (2011) Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro. Malaria Journal, 10, 187.
http://www.malariajournal.com/content/10/1/187
doi:10.1186/1475-2875-10-187
|